BayCare Integrated Service Center LLC — FDA Facility Profile
BayCare Integrated Service Center LLC is an FDA-inspected facility (FEI 3013023419) located in Temple Terrace, FL, US. RegDataLab tracks 2 FDA inspections at this facility.
Reviewing BayCare Integrated Service Center LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check BayCare Integrated Service Center LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
What FDA found at this site
- Latest inspection
- Jun 2, 2023: Voluntary Action Indicated (VAI)
- Inspections on record
- 2 (2 VAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Form 483 and inspection documents
- 4 in FDA's reading room
- Recalls as the recalling firm
- 3, latest Dec 1, 2022
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Jun 2, 2023 | Voluntary Action Indicated (VAI) | Drug product labels, fails to include (FDCA 503B(a)(10)(A)) |
| Dec 10, 2019 | Voluntary Action Indicated (VAI) | Approve or reject procedures or specs (21 CFR 211.22(c)) Procedures not in writing, fully followed (21 CFR 211.22(d)) Environmental Monitoring System (21 CFR 211.42(c)(10)(iv)) Investigations of discrepancies, failures (21 CFR 211.192) and 1 more |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Dec 1, 2022 | Not yet classified | D-0086-2023 | Iohexol (300 mg Iodine/mL), 2.4 g Iodine/8 ml, Total Volume 8 ml in 10 ml syringe, 5-count… Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL |
| Feb 14, 2022 | Not yet classified | D-0569-2022 | Norepinephrine bitartrate 16 mg in 250 mL NaCl 0.9%, packaged in IV bags, Rx only, BayCare… Subpotent drug |
| Jul 30, 2021 | Not yet classified | D-0702-2021 | Succinylcholine Chloride 100 mg/5 mL (20 mg/mL), 5 mL Syringes, Rx only, For IV Use only… Lack of sterility assurance |
Form 483s and inspection documents
- Mar 12, 2026: 483 on FDA.gov
- Jun 2, 2023: 483 on FDA.gov
- Sep 13, 2021: Untitled Letter on FDA.gov
- Dec 10, 2019: 483 on FDA.gov
Facility details
- Company
- BayCare Integrated Service Center LLC
- Location
- Temple Terrace, FL (US)
- Source
- inspections